Presentation Information
[28-20-pm01S]Cumulative risk and predictors of urinary protein expression during long-term anti-VEGF treatment in patients with RAS-mutant colorectal cancer
○Yuto Miura1, Misato Kani1, Daichi Watanabe2, Hironori Hujii2, Yunami Yamada2, Koichi Ohata2, Chiemi Hirose2, Hirotoshi Iihara2, Wakana Chikaishi3, Jesse Yu Tajima3, Akiyoshi Makiyama4, Nobuhisa Matsuhashi3, Ryo Kobayashi1,2, Akio Suzuki1,2 (1. Gifu. Pharm. Univ., 2. Dept. Pharm. Gifu. Univ. Hosp, 3. Grad. Sch. Med. Gifu Univ., 4. Cancer Cent. Gifu Univ. Hosp.)